New IBD treatment shows promise for ulcerative colitis and Crohn’s disease

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, new research finds.

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, according to findings from two new trials.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

“These studies are really quite significant,” said Dr. Uma Mahadevan, a gastroenterologist and an expert on inflammatory bowel disease at the University of California, San Francisco.

The two randomized controlled trials provide, for the first time, hard data to support combination drug therapy to fight inflammatory bowel disease, said Mahadevan, who has no connection to the studies.